PGEN — Precigen Income Statement
0.000.00%
Last trade - 00:00- $331.06m
- $268.21m
- $6.23m
Annual income statement for Precigen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 90.7 | 103 | 14.3 | 26.9 | 6.22 |
| Cost of Revenue | |||||
| Gross Profit | 29.3 | 47.7 | 8.52 | 20.6 | 0.106 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 258 | 190 | 106 | 103 | 106 |
| Operating Profit | -167 | -86.6 | -91.9 | -75.7 | -99.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -171 | -104 | -111 | -80 | -96.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -170 | -104 | -111 | -79.8 | -95.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -322 | -171 | -92.2 | 28.3 | -95.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -322 | -171 | -92.2 | 28.3 | -95.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.965 | -0.618 | -0.559 | -0.395 | -0.364 |